BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced a collaboration with Tempus, a technology...
MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that the first patient has been dosed in...
Nuntius Therapeutics, a biotech company developing transformative mRNA therapies through their advanced delivery technology, announced that they have entered into a collaboration agreement with...
Audax Private Equity announced it has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. The deal is expected...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
